Wästerström S A
Scand Audiol Suppl. 1984;23:1-40.
The aim of this study was to obtain more information about the possible role of melanin in the hearing process and to investigate the ototoxic and therapeutic effects of certain drugs with known affinity to this pigment. In order to obtain hearing threshold curves, young albino and pigmented guinea pigs were tested by N1-electrocochleography. There were no significant differences between the curves for the two strains, indicating that melanin has no major influence on the hearing process in young guinea pigs under normal conditions at thresholds. The acute and long-term ototoxic effect of kanamycin, an aminoglycoside antibiotic capable of accumulating on melanin in vitro, was studied in albino and pigmented guinea pigs by electrophysiological and morphological methods. In the highest dose used, 200 mg/kg/day, kanamycin caused significantly more damage in the pigmented guinea pigs than in the albino ones. To elucidate the possible role of melanin affinity in pharmacological treatment of tinnitus and the site of action of lidocaine and tocainide, nine patients with disabling tinnitus were treated with lidocaine, QX-572 (a quaternary derivative of lidocaine which does not readily penetrate the blood-brain barrier) and tocainide (an amine analogue of lidocaine which can be taken orally). In six patients all three substances had a beneficial effect, but in the remaining three patients none of them produced any response. Autoradiographic studies in rats, both in vivo and in vitro, showed that all three substances accumulated on inner ear melanin. Auditory brainstem-evoked responses (ABRs) were measured in 10 healthy male subjects after single-dose injections of the respective drugs, in doses normally reducing tinnitus in sensitive patients. Neither drug produced any significant change in ABR. The results of these studies support a hypothesis that accumulation of drugs on inner ear melanin can constitute both an ototoxic and a therapeutic mechanism.
本研究的目的是获取更多关于黑色素在听觉过程中可能作用的信息,并研究某些对该色素具有已知亲和力的药物的耳毒性和治疗效果。为了获得听力阈值曲线,采用N1-电耳蜗图对年轻的白化豚鼠和有色豚鼠进行了测试。两种品系的曲线之间没有显著差异,这表明在正常条件下,黑色素对年轻豚鼠阈值处的听觉过程没有重大影响。通过电生理和形态学方法,对白化豚鼠和有色豚鼠研究了卡那霉素(一种能够在体外积聚在黑色素上的氨基糖苷类抗生素)的急性和长期耳毒性作用。在使用的最高剂量(200mg/kg/天)下,卡那霉素对有色豚鼠造成的损害明显大于对白化豚鼠的损害。为了阐明黑色素亲和力在耳鸣药物治疗中的可能作用以及利多卡因和妥卡尼的作用部位,对9名患有致残性耳鸣的患者使用利多卡因、QX-572(利多卡因的季铵衍生物,不易穿透血脑屏障)和妥卡尼(利多卡因的胺类似物,可口服)进行治疗。在6名患者中,所有三种物质都有有益效果,但在其余3名患者中,它们均未产生任何反应。对大鼠进行的体内和体外放射自显影研究表明,所有三种物质都积聚在内耳黑色素上。在10名健康男性受试者单次注射各自药物后,测量了听觉脑干诱发电位(ABR),注射剂量通常可减轻敏感患者的耳鸣。两种药物均未使ABR产生任何显著变化。这些研究结果支持了一种假说,即药物在内耳黑色素上的积聚既可以构成耳毒性机制,也可以构成治疗机制。